title: Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma.
authors.affiliation: Department of Hematology, Hospital del Mar - IMIM , Barcelona , Spain.
authors.forename: Blanca
authors.initials: B
authors.lastname: Sanchez-Gonzalez
authors.forename: Eva
authors.initials: E
authors.lastname: Gimeno
authors.forename: Francesc
authors.initials: F
authors.lastname: Garcia-Pallarols
authors.forename: Agueda
authors.initials: A
authors.lastname: Ancochea
authors.forename: Antonio
authors.initials: A
authors.lastname: Salar
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000473:pathology*; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000473:pathology*; D060046:Maintenance Chemotherapy; D009364:Neoplasm Recurrence, Local; D019233:Retreatment; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab